SARS-CoV-2 fragments found to mimic immune system peptides, fueling inflammation

Study reveals SARS-CoV-2 fragments mimic immune peptides, potentially driving the virus’s inflammatory response, offering insights into COVID-19’s severe inflammation mechanisms.

Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal Drugs in R&D – Biotech Investments

EQS-News: Formycon AG / Key word(s): Scientific publication/Study results Formycon published results of analytical similarity study of biosimilar candidate FYB206 and Keytruda® in peer-reviewed journal

October 17, 2024

New technology streamlines drug discovery using single-molecule tracking

New drug discovery is a critical step for improving patients’ lives. First, researchers must identify molecules in the body’s cells that help drive disease, as

November 1, 2024

Oncologists turn to blood test for circulating tumor DNA, but questions remain on how to use the data

The hope for many cancer patients who go through surgery is that they’ll be cured after the surgeon removes the tumor. The question that lingers

June 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.